LOW-VOLUME · HOSP-HEAVY
griseofulvin Side Effects
griseofulvin (also sold as Grifulvin V) is a LOW-VOLUME FAERS extract #514 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 33.8% mention hospitalization (94 reports).
Data updated 2026-05-15
- 278
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
griseofulvin: 33.8% mention hospitalization (94 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #514 of 524 by FAERS report count.
Thinner FAERS extract for griseofulvin (Grifulvin V) (278 reports #514 of 524 by FAERS report count). 33.8% mention hospitalization (94 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
HEADACHE leads 15 of 278 reports
Who reports · age peak 18-44 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 18-44 (56 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (15 reports, 5.4%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 6 |
| CEREBELLAR INFARCTION | 3 |
| CEREBRAL TOXOPLASMOSIS | 3 |
| DIARRHOEA | 3 |
| ORAL CANDIDIASIS | 3 |
| DYSPNOEA | 2 |
| MENINGITIS | 2 |
| ABSCESS FUNGAL | 1 |
| ACUTE RESPIRATORY DISTRESS SYNDROME | 1 |
| ASTHENIA | 1 |
| DERMATOPHYTOSIS | 1 |
| DISEASE RECURRENCE | 1 |
| DRUG HYPERSENSITIVITY | 1 |
| EOSINOPHILIC PNEUMONIA | 1 |
| FISTULA | 1 |
| FOETAL EXPOSURE DURING PREGNANCY | 1 |
| GANGRENE | 1 |
| GLOMERULONEPHRITIS PROLIFERATIVE | 1 |
| GRANULOMA | 1 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (94, 33.8% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS | 9 |
| DELIRIUM | 8 |
| DRUG INTERACTION | 8 |
| DIARRHOEA | 7 |
| LINEAR IGA DISEASE | 7 |
| PAIN | 7 |
| ERYTHEMA MULTIFORME | 6 |
| ACUTE KIDNEY INJURY | 5 |
| OEDEMA PERIPHERAL | 5 |
| TUBULOINTERSTITIAL NEPHRITIS | 5 |
| ANXIETY | 4 |
| FATIGUE | 4 |
| FOCAL SEGMENTAL GLOMERULOSCLEROSIS | 4 |
| PYREXIA | 4 |
| RASH | 4 |
| RENAL FAILURE | 4 |
| TOXIC EPIDERMAL NECROLYSIS | 4 |
| CEREBELLAR INFARCTION | 3 |
| CEREBRAL TOXOPLASMOSIS | 3 |
How to read griseofulvin FAERS figures (TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 278 voluntary reports linked to griseofulvin (Grifulvin V), 2004-2025. Death is listed on 15 (5.4%). Hospitalization appears on 94 (33.8%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with griseofulvin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 299 FAERS cases (Δ 21 heavier vs griseofulvin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 318 FAERS cases (Δ 40 heavier vs griseofulvin); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 329 FAERS cases (Δ 51 heavier vs griseofulvin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 218 FAERS cases (Δ 60 lighter vs griseofulvin); DEATH-MARKED · HOSP-HEAVY · SEX-BALANCED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 56.7 pp vs griseofulvin's DEATH-HEAVY): CASELOAD · HOSP-MID.
griseofulvin stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload TRACE-CASE and the label guide.